Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$189.50
-0.7%
$187.30
$163.63
$218.66
$334.73B0.486.25 million shs3.71 million shs
Equinix, Inc. stock logo
EQIX
Equinix
$787.50
-1.0%
$866.92
$701.41
$994.03
$77.03B0.93556,961 shs539,869 shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$155.90
+0.2%
$153.65
$140.68
$169.99
$375.11B0.418.05 million shs3.48 million shs
Walmart Inc. stock logo
WMT
Walmart
$98.29
+0.7%
$97.07
$66.67
$105.30
$784.40B0.6818.08 million shs7.69 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-0.67%+1.30%+1.24%+1.57%+15.66%
Equinix, Inc. stock logo
EQIX
Equinix
-0.96%+5.63%-12.00%+2.78%+5.14%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.20%+2.40%+0.94%+1.88%+7.06%
Walmart Inc. stock logo
WMT
Walmart
+0.69%+2.15%-1.72%+18.29%+44.04%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.9065 of 5 stars
3.45.03.33.92.81.71.3
Equinix, Inc. stock logo
EQIX
Equinix
4.8281 of 5 stars
3.53.03.32.93.12.51.3
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8506 of 5 stars
2.35.04.23.93.11.71.9
Walmart Inc. stock logo
WMT
Walmart
4.7706 of 5 stars
2.55.03.31.83.42.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.81
Moderate Buy$211.2911.50% Upside
Equinix, Inc. stock logo
EQIX
Equinix
3.04
Buy$960.5521.97% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.889.61% Upside
Walmart Inc. stock logo
WMT
Walmart
2.97
Moderate Buy$106.678.52% Upside

Current Analyst Ratings Breakdown

Latest ABBV, EQIX, JNJ, and WMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/3/2025
Equinix, Inc. stock logo
EQIX
Equinix
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/2/2025
Equinix, Inc. stock logo
EQIX
Equinix
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$1,020.00 ➝ $880.00
7/2/2025
Walmart Inc. stock logo
WMT
Walmart
Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$115.00 ➝ $120.00
7/1/2025
Equinix, Inc. stock logo
EQIX
Equinix
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$1,069.00 ➝ $900.00
7/1/2025
Equinix, Inc. stock logo
EQIX
Equinix
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$986.00 ➝ $904.00
6/26/2025
Equinix, Inc. stock logo
EQIX
Equinix
Cfra Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Moderate Buy
6/26/2025
Equinix, Inc. stock logo
EQIX
Equinix
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$1,050.00 ➝ $1,010.00
6/26/2025
Equinix, Inc. stock logo
EQIX
Equinix
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$1,065.00 ➝ $925.00
6/26/2025
Equinix, Inc. stock logo
EQIX
Equinix
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$1,200.00
6/26/2025
Equinix, Inc. stock logo
EQIX
Equinix
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$975.00 ➝ $935.00
6/26/2025
Equinix, Inc. stock logo
EQIX
Equinix
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Sector Outperform$1,030.00 ➝ $965.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B5.94$14.84 per share12.77$1.90 per share99.74
Equinix, Inc. stock logo
EQIX
Equinix
$8.85B8.71$29.19 per share26.98$140.19 per share5.62
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$89.33B4.20$13.15 per share11.86$29.69 per share5.25
Walmart Inc. stock logo
WMT
Walmart
$680.99B1.15$4.16 per share23.61$11.32 per share8.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.3580.6413.561.277.31%412.03%13.11%7/24/2025 (Estimated)
Equinix, Inc. stock logo
EQIX
Equinix
$815M$9.6281.8621.821.1410.48%6.96%2.66%8/6/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9917.3414.082.3524.42%33.46%13.30%7/16/2025 (Estimated)
Walmart Inc. stock logo
WMT
Walmart
$19.44B$2.3442.0032.554.702.75%21.76%7.79%8/21/2025 (Estimated)

Latest ABBV, EQIX, JNJ, and WMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$3.24N/AN/AN/A$14.93 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
5/15/2025Q1 2026
Walmart Inc. stock logo
WMT
Walmart
$0.58$0.61+$0.03$0.56$164.53 billion$165.61 billion
4/30/2025Q1 2025
Equinix, Inc. stock logo
EQIX
Equinix
$9.01$9.67+$0.66$9.67$2.23 billion$2.23 billion
4/25/2025Q1 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$2.40$2.46+$0.06$0.72$12.91 billion$13.34 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.46%N/A279.15%53 Years
Equinix, Inc. stock logo
EQIX
Equinix
$18.762.38%N/A195.01%10 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.34%N/A57.84%64 Years
Walmart Inc. stock logo
WMT
Walmart
$0.940.96%N/A40.17%53 Years

Latest ABBV, EQIX, JNJ, and WMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/20/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.54%7/15/20257/15/20258/15/2025
4/30/2025
Equinix, Inc. stock logo
EQIX
Equinix
quarterly$4.692.18%5/21/20255/21/20256/18/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
5/3/2025
Walmart Inc. stock logo
WMT
Walmart
$0.23500.95%5/9/20255/12/20255/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
44.14
0.76
0.64
Equinix, Inc. stock logo
EQIX
Equinix
1.20
1.65
1.65
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03
Walmart Inc. stock logo
WMT
Walmart
0.47
0.78
0.22

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Equinix, Inc. stock logo
EQIX
Equinix
94.94%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Walmart Inc. stock logo
WMT
Walmart
26.76%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
Equinix, Inc. stock logo
EQIX
Equinix
0.27%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Walmart Inc. stock logo
WMT
Walmart
45.58%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
55,0001.77 billion1.76 billionOptionable
Equinix, Inc. stock logo
EQIX
Equinix
13,60697.82 million97.56 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Walmart Inc. stock logo
WMT
Walmart
2,100,0007.98 billion4.34 billionOptionable

Recent News About These Companies

Top Ecommerce Stocks To Research - July 4th
Top Outdoor Stocks Worth Watching - July 4th
Walmart July 4th Hours: What to Know for 2025
Walmart Inc. (NYSE:WMT) Shares Sold by Conning Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$189.50 -1.25 (-0.66%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$188.90 -0.60 (-0.32%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Equinix stock logo

Equinix NASDAQ:EQIX

$787.50 -7.65 (-0.96%)
Closing price 07/3/2025 03:50 PM Eastern
Extended Trading
$792.10 +4.61 (+0.58%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Equinix (Nasdaq: EQIX) is the world's digital infrastructure company . Digital leaders harness Equinix's trusted platform to bring together and interconnect foundational infrastructure at software speed. Equinix enables organizations to access all the right places, partners and possibilities to scale with agility, speed the launch of digital services, deliver world-class experiences and multiply their value, while supporting their sustainability goals.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$155.90 +0.34 (+0.22%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$155.75 -0.15 (-0.10%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Walmart stock logo

Walmart NYSE:WMT

$98.29 +0.68 (+0.70%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$98.25 -0.04 (-0.04%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications. The company offers grocery and consumables, including dairy, meat, bakery, deli, produce, dry, chilled or frozen packaged foods, alcoholic and nonalcoholic beverages, floral, snack foods, candy, other grocery items, health and beauty aids, paper goods, laundry and home care, baby care, pet supplies, and other consumable items; fuel, tobacco and other categories. It is also involved in the provision of health and wellness products covering pharmacy, optical and hearing services, and over-the-counter drugs and other medical products; and home and apparel including home improvement, outdoor living, gardening, furniture, apparel, jewelry, tools and power equipment, housewares, toys, seasonal items, mattresses and tire and battery centers. In addition, the company offers consumer electronics and accessories, software, video games, office supplies, appliances, and third-party gift cards. Further, it operates digital payment platforms; and offers financial services and related products, including money transfers, bill payments, money orders, check cashing, prepaid access, co-branded credit cards, installment lending, and earned wage access. Additionally, the company markets lines of merchandise under private brands, including Allswell, Athletic Works, Equate, and Free Assembly. The company was formerly known as Wal-Mart Stores, Inc. and changed its name to Walmart Inc. in February 2018. Walmart Inc. was founded in 1945 and is based in Bentonville, Arkansas.